2nd Quarter - Report
MYRIAD GENETICS, INC. for MYRIAD GENETICS, INC.
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression Regulations governing Medicare Advantage plans and the use of prior authorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SHEIVES New | — |
Medical/Disease Research/Clinical Labs MED
FDA rulemaking to regulate laboratory developed tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SHEIVES New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.